Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.

ABSTRACT:

SUBMITTER: Mura C 

PROVIDER: S-EPMC8278809 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature